bromodeoxyuridine has been researched along with 2,2'-(hydroxynitrosohydrazono)bis-ethanamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chopp, M; Lapointe, M; Lu, M; Wang, Y; Zhang, L; Zhang, R; Zhang, Z | 1 |
| Chen, J; Chopp, M; Wang, L; Zhang, L; Zhang, R; Zhang, Z; Zhu, Z | 1 |
| Copp, M; Lu, D; Mahmood, A; Zhang, R | 1 |
3 other study(ies) available for bromodeoxyuridine and 2,2'-(hydroxynitrosohydrazono)bis-ethanamine
| Article | Year |
|---|---|
A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Movement; Cerebral Cortex; Cyclic GMP; Dentate Gyrus; Disease Models, Animal; Infarction, Middle Cerebral Artery; Lateral Ventricles; Male; Neurons; Nitric Oxide Donors; Nitroso Compounds; Rats; Rats, Wistar; Stroke; Treatment Outcome | 2001 |
Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Brain; Bromodeoxyuridine; Cell Division; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Piperazines; Purines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Sildenafil Citrate; Soluble Guanylyl Cyclase; Stroke; Sulfones; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2003 |
Upregulation of neurogenesis and reduction in functional deficits following administration of DEtA/NONOate, a nitric oxide donor, after traumatic brain injury in rats.
Topics: Animals; Brain Injuries; Bromodeoxyuridine; Cell Division; Cell Movement; Cerebral Cortex; Corpus Callosum; Corpus Striatum; Disease Models, Animal; Drug Administration Schedule; Hippocampus; Injections, Intraperitoneal; Male; Nitric Oxide Donors; Nitroso Compounds; Psychomotor Disorders; Radiation-Sensitizing Agents; Random Allocation; Rats; Rats, Wistar; Recovery of Function; Stem Cells; Time Factors; Up-Regulation | 2003 |